Objective: Chronic cold exposure causes white adipose tissue (WAT) to adopt features of brown adipose tissue (BAT), a process known as browning. Previous studies have hinted at a possible role for the transcription factor Peroxisome Proliferator-Activated Receptor alpha (PPARa) in cold-induced browning. Here we aimed to investigate the importance of PPARa in driving transcriptional changes during cold-induced browning in mice. Methods: Male wildtype and PPARaÀ/À mice were housed at thermoneutrality (28 C) or cold (5 C) for 10 days. Whole genome expression analysis was performed on inguinal WAT. In addition, other analyses were carried out. Whole genome expression data of livers of wildtype and PPARaÀ/À mice fasted for 24 h served as positive control for PPARa-dependent gene regulation. Results: Cold exposure increased food intake and decreased weight of BAT and WAT to a similar extent in wildtype and PPARaÀ/À mice. Except for plasma non-esterified fatty acids, none of the cold-induced changes in plasma metabolites were dependent on PPARa genotype. Histological analysis of inguinal WAT showed clear browning upon cold exposure but did not reveal any morphological differences between wildtype and PPARaÀ/À mice. Transcriptomics analysis of inguinal WAT showed a marked effect of cold on overall gene expression, as revealed by principle component analysis and hierarchical clustering. However, wildtype and PPARaÀ/À mice clustered together, even after cold exposure, indicating a similar overall gene expression profile in the two genotypes. Pathway analysis revealed that cold upregulated pathways involved in energy usage, oxidative phosphorylation, and fatty acid b-oxidation to a similar extent in wildtype and PPARaÀ/À mice. Furthermore, cold-mediated induction of genes related to thermogenesis such as Ucp1, Elovl3, Cox7a1, Cox8, and Cidea, as well as many PPAR target genes, was similar in wildtype and PPARaÀ/À mice. Finally, pharmacological PPARa activation had a minimal effect on expression of cold-induced genes in murine WAT. Conclusion: Cold-induced changes in gene expression in inguinal WAT are unaltered in mice lacking PPARa, indicating that PPARa is dispensable for cold-induced browning.
INTRODUCTION
Cold exposure in mice causes specific white adipose tissue (WAT) depots to adopt features of brown adipose tissue (BAT), a process known as browning [1] . Browning is characterized by the appearance of adipocytes with multiple lipid droplets and by the acquisition of a thermogenic capacity, the latter of which is dependent on an increase in uncoupling protein (UCP) 1 [2] . Concurrent with the changes in cell morphology, the transcription of numerous genes involved in thermogenesis and lipid catabolism is strongly activated [3] . Recently, it was shown that human white adipose tissue is also capable of browning under condition of prolonged and severe adrenergic stress [4] . Nowadays, browning is considered as a potential molecular target to promote weight loss and improve metabolic risk factors, prompting investigation into the molecular mechanisms that drive browning. One of the transcription factors that has been implicated in browning is PPARa [5] . PPARa is a member of the family of Peroxisome Proliferator-Activated Receptors, which play key roles in the regulation of lipid homeostasis and oxidative metabolism [6e8] . Three different PPAR subtypes exist in mammals: PPARa, PPARd (also referred to as PPARb), and PPARg, each with a distinct tissue expression profile and set of functions. PPARs regulate gene expression in response to binding small lipophilic ligands and function as a heterodimeric complex with the retinoid X receptor RXR [9e11] . The ligands forranging from industrial chemicals to specific drug classes, fatty acids, eicosanoids, and other lipid species [12] . The PPARa subtype is expressed in several tissues, with the highest expression levels in mice found in brown adipose tissue (BAT) and liver, followed by kidney, heart, skeletal muscle and intestine [13, 14] . At the physiological level, PPARa is mainly known as the master regulator of lipid metabolism in the liver during fasting. This notion is based on the finding that fasted whole-body or liver-specific PPARaÀ/À mice have a severe metabolic phenotype characterized by hypoglycemia, hypoketonemia, elevated plasma non-esterified fatty acids (NEFAs), and a fatty liver [15e17] . These metabolic defects are rooted in reduced expression of hundreds of genes involved in numerous metabolic pathways covering nearly every aspect of hepatic lipid metabolism [18] . The PPARg subtype is predominantly expressed in colonocytes, macrophages, and adipocytes [13] . It is mainly known as the target for the insulin-sensitizing thiazolidinedione drugs [19] . In addition, PPARg is essential for the differentiation of brown and white adipocytes [20] . In mice, loss of PPARg fails to yield viable offspring [21] , while in humans homozygosity for loss-of-function mutations in PPARg leads to a form of lipodystrophy [22] . Both PPARa and PPARg have been implicated in browning [5] . With respect to PPARg, treatment of mice with synthetic PPARg agonists promotes adipose tissue browning, as shown by the appearance of multilocular adipocytes and the increased expression of thermogenic genes such as Ucp1, triggering thermogenic capacity in WAT [23e25] . Conversely, mice carrying a functionally impaired mutant form of PPARg have reduced adipose tissue browning and an impaired thermogenic capacity after treatment with the b3-adrenergic agonist CL316,243 [26] . Furthermore, activation of PPARg in human preadipocytes and adipocytes increased expression of UCP1 and other browning-related genes [27, 28] . The role of PPARa in browning is less clear. Although a number of studies have implicated PPARa in CL316,243-induced browning [27, 29] , no studies have carefully examined the transcriptional role of PPARa during cold-induced browning. Based on the reported attenuation of browning by PPARa ablation after CL316,243 treatment [27, 29] , and considering the marked induction of PPARa mRNA and protein during cold-induced browning [30, 31] , we hypothesized that PPARa is essential for stimulating gene expression in inguinal WAT in response to cold. The objective of this study was to verify this hypothesis and investigate the importance of PPARa in cold-induced browning in mice.
METHODS

Animals and diet
Male and female wildtype and PPARaÀ/À mice that had been backcrossed on a pure C57Bl/6J background for more than 10 generations were acquired from Jackson Laboratories (no. 000664 and 008154, respectively). The mice were further bred at the animal facility of Wageningen University under specific pathogen free conditions to generate the number of mice necessary for the experiments. For the chronic cold experiment, 40 three-to four-month-old male wildtype and PPARaÀ/À mice were placed at thermo-neutral temperature (28 C) for 5 weeks. Thereafter, 20 wildtype and 20 PPARaÀ/À mice were randomly distributed across 2 groups: half of the mice of each genotype were kept at thermo-neutral temperature and half of the mice of each genotype was placed at 21 C for one week followed by a period of 10 days in the cold (5 C) (n ¼ 10 per group). For cold exposure, mouse cages were placed in a cold cabinet that was kept at 5 C (ELDG800, VDW Coolsystems, Geldermalsen). Mice had ad libitum access to chow feed and water. Body weight and body temperature were monitored daily during the cold exposure period. Body temperature of the coldexposed mice was monitored via read-out of transponders (IPTT-300) that were injected subcutaneously prior to the experiment (Bio Medic Data Systems, Seaford, USA). For the acute cold experiment, three-to four-month-old male wildtype and PPARaÀ/À mice were placed at thermo-neutral temperature (28 C) for 5 weeks. Thereafter, the mice were placed in the cold (5 C) for 24 h (n ¼ 10 per group). For the fasting experiment, three-to four-month-old male wildtype and PPARaÀ/À mice were either fasted for 24 h or had food available ad libitum (n ¼ 10e11 per group). For PPAR agonist treatment, Sv129 male mice were placed on a high fat diet (formula D12451 Research Diets, Inc., manufactured by Research Diet Services, Wijk bij Duurstede) for 21 weeks with the addition of Wy14,643 (0.1% w/w of feed) or rosiglitazone (0.01% w/w of feed) during the last week. All mice were housed at the animal facility of Wageningen University. Mice were housed in individual cages with normal bedding and cage enrichment on a 12 h lightedark cycle. They had visual and auditory contact with littermates. At the end of the study, between 9.00h and 11.00h, blood was collected via orbital puncture under isoflurane anesthesia into EDTA tubes. Mice were euthanized via cervical dislocation, after which tissues were excised and directly frozen in liquid nitrogen or prepared for histology. All studies were approved by the Animal Ethics Committee of Wageningen University and by the Central Animal Testing Committee (CCD, AVD104002015236).
RNA isolation and quantitative PCR
Total RNA was extracted from cells using TRIzol reagent (Life Technologies, Bleiswijk, The Netherlands). For tissues, total RNA was isolated using the RNeasy Micro kit from Qiagen (Venlo, The Netherlands). Subsequently, 500 ng RNA was used to synthesize cDNA using iScript cDNA synthesis kit (Bio-Rad Laboratories, Veenendaal, The Netherlands). Messenger RNA levels of selected genes were determined by reverse transcription quantitative PCR using SensiMix (Bioline; GC Biotech, Alphen aan den Rijn, The Netherlands) on a CFX384 real-time PCR detection system (Bio-Rad Laboratories, Veenendaal, the Netherlands). The housekeeping gene 36b4 was used for normalization.
Histology/immunohistochemistry
Fresh WAT tissues were fixed in 4% paraformaldehyde, dehydrated, and embedded in paraffin. Hematoxilin & Eosin staining was performed using standard protocols.
Plasma measurements
Plasma concentrations of glucose (Sopachem, Ochten, the Netherlands), triglycerides, cholesterol, ketone bodies (Instruchemie, Delfzijl, the Netherlands), glycerol (SigmaeAldrich, Houten, the Netherlands), and non-esterified fatty acids (Wako Chemicals, Neuss, Germany; HR(2) Kit) were determined following the manufacturers' instructions.
Liver triglycerides
Liver triglyceride levels were determined in 10% liver homogenates prepared in buffer containing Sucrose 250 mM, EDTA 1 mM, TriseHCl 10 mM pH 7.5 using a commercially available kit from Instruchemie (Delfzijl, The Netherlands).
Microarray analysis
Microarray analysis was performed on inguinal adipose tissue samples from 5 to 6 mice of each group and liver samples from 5 mice per group. RNA was isolated as described above and subsequently purified using the RNeasy Micro kit from Qiagen (Venlo, The Netherlands). RNA integrity was verified with RNA 6000 Nano chips on an Agilent 2100 bioanalyzer (Agilent Technologies, Amsterdam, The Netherlands). Purified RNA (100 ng) was labeled with the Ambion WT expression kit (Carlsbad, CA) and hybridized to an Affymetrix Mouse Gene 1.1 ST array plate (Affymetrix, Santa Clara, CA). Hybridization, washing, and scanning were carried out on an Affymetrix GeneTitan platform according to the manufacturer's instructions. Normalized expression estimates were obtained from the raw intensity values applying the robust multi-array analysis preprocessing algorithm available in the Bioconductor library AffyPLM with default settings [32, 33] . Probe sets were defined according to Dai et al. [34] . In this method probes are assigned to Entrez IDs as a unique gene identifier. In this study, probes were reorganized based on the Entrez Gene database, build 37, version 1 (remapped CDF v22). The microarray dataset was filtered by only including probe sets with expression values higher than 20 on at least 4 arrays. In addition, an Inter Quartile Range (IQR) cut-off of 0.25 was used to filter out genes that showed no variation between the conditions, leaving a total of 8174 genes for further statistical analysis. The P values were calculated using an Intensity-Based Moderated T-statistic (IBMT) [35] . Genes were defined as significantly changed when P < 0.001. Gene set enrichment analysis (GSEA) was used to identify gene sets that were enriched among the upregulated or downregulated genes [36] . Genes were ranked based on the IBMT-statistic and subsequently analyzed for over-or underrepresentation in predefined gene sets derived from Gene Ontology, KEGG, National Cancer Institute, PFAM, Biocarta, Reactome and WikiPathways pathway databases. Only gene sets consisting of more than 15 and fewer than 500 genes were taken into account. Statistical significance of GSEA results was determined using 1,000 permutations. As an alternative strategy to identify pathways up-or down-regulated by cold or fasting, Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, CA) was performed. Input criteria were a relative fold change equal to or above 1.5 and an IBMT P-value<0.001. Array data have been submitted to the Gene Expression Omnibus (GSE110420). The microarray analysis on livers of fed and fasted wildtype and PPARaÀ/À mice was previously published (GSE17863) [37] , as was the microarray analysis on WAT of PPAR agonist treated mice (GSE11295) [38] .
2.7. Isolation and differentiation of primary adipocytes WAT was dissected from wild-type and PPARaÀ/À mice and put in DMEM supplemented with 1% Pen/Strep and 1% BSA. Tissues of 3 mice were pooled, minced with scissors, and digested for 1 h at 37 C in collagenase-containing medium (DMEM with 3.2 mM CaCl 2 , 1.5 mg/ml collagenase type II (SigmaeAldrich), 10% FBS, 0.5% BSA (SigmaAldrich) and 15 mM HEPES). After digestion, the cell mixture was passed over a 100 mm cell strainer and centrifuged at 1600 rpm for 10 min.
Supernatant was removed and the pellet containing the stromal vascular fraction was re-suspended in erythrocyte lysis buffer (155 mM NH 4 Cl, 12 mM NaHCO 3 , 0.1 mM EDTA) and incubated for 2e3 min at room temperature. Following neutralization, cells were centrifuged at 1200 rpm for 5 min. Cells were re-suspended in DMEM containing 10% FBS and 1% Pen/Strep and plated. Upon confluence, cells were differentiated following standard protocol of 3T3-L1 cells, as described previously [39] .
Isolation and differentiation of human primary adipocytes derived from WAT
The isolation and differentiation of adipocytes derived from human WAT has been described before [40] . In short, the stromal vascular fraction was obtained from subcutaneous WAT during thyroid surgery using a collagenase digestion. Differentiation was initiated for 7 days with differentiation medium containing biotin (33 mM), pantothenate (17 mM), insulin (100 nM), dexamethasone (100 nM), IBMX (250 mM), rosiglitazone (5 mM), T3 (2 nM), and transferrin (10 mg/ml). Cells were transferred to maintenance medium consisting of biotin (33 mM), pantothenate (17 mM), insulin (100 nM), dexamethasone (10 nM), T3 (2 nM), and transferrin (10 mg/ml) for another 5 days in the presence of absence of 300 nM GW7647. The study was reviewed and approved by the ethics committee of Maastricht University Medical Center (METC 10-3-012, NL31367.068.10). Informed consent was obtained before surgery, and participants did not receive a stipend.
2.9. Oxygen consumption in differentiated adipocytes derived from human BAT Differentiated adipocytes were incubated for 1 h at 37 C in unbuffered XF assay medium supplemented with 2 mM GlutaMAX, 1 mM sodium pyruvate, and 25 mM glucose. To determine NE-stimulated mitochondrial uncoupling, oxygen consumption was measured using bioanalyzer from Seahorse Bioscience after addition of 2 mM oligomycin, which inhibited ATPase, followed by 1 mM NE. Maximal respiration was determined following 0.3 mM FCCP-induced determined. 1 mM antimycin A and rotenone was added to correct for non-mitochondrial respiration.
Statistical analysis
Data are presented as mean AE SEM. Comparisons between two groups were made using two-tailed Student's t-test. P < 0.05 was considered as statistically significant. Excel software (version 2016) was used for statistical analysis.
RESULTS
PPARa and PPARa target genes are upregulated during coldinduced browning
Quantitative PCR indicated that Ppara mRNA levels were markedly increased in inguinal WAT but not gonadal WAT after 10 days of cold exposure as compared to thermoneutrality ( Figure 1A ), suggesting a role of PPARa in cold-induced browning in mice. The mRNA expression level of Ppara in inguinal WAT after cold approaches the robust expression level of Ppara in brown fat ( Figure 1B ). Analysis of an existing microarray dataset (GSE51080) indicated that Ppara is among the most highly induced genes in murine inguinal adipose tissue in response to cold ( Figure 1C ) [41] . Along with Ppara and genes associated with browning such as Ucp1, Cidea, and Elovl3, many target genes of PPARa were highly induced by cold in inguinal WAT, including Pank1, Slc25a20, Pdk4, Fbp2, Plin5, Acadl and Acaa2 ( Figure 1C) . A large similarity was observed between the inductions in gene expression elicited by cold in inguinal adipose tissue and the gene expression changes caused by PPARa activation in the liver using a synthetic PPARa agonist ( Figure 1C ), again suggesting activation of PPARa in inguinal WAT during cold. Similar results were obtained using another microarray dataset on the effect of cold in murine inguinal WAT (GSE13432, Supplemental Figure 1 ) [42] . According to gene set enrichment analysis, PPARa target genes were also highly enriched among the cold-induced genes ( Figure 1D ). Together, these data suggest a possible role for PPARa in coldinduced browning. 3.2. Cold-induced changes in WAT morphology are unaltered in PPARaÀ/À mice To investigate the role of PPARa in cold-induced browning, male wildtype and PPARaÀ/À mice were studied after 10 days of cold exposure (5 C) (Figure 2A ). For comparison, another group of wildtype and PPARaÀ/À were studied after a prolonged stay at thermoneutrality (28 C). Cold exposure caused a transient decrease in body temperature, which was significantly more pronounced in the PPARaÀ/À mice than in the wildtype mice ( Figure 2B) . The difference in body temperature disappeared after prolonged cold exposure ( Figure 2C ). As expected, cold exposure markedly increased food intake ( Figure 2D ). However, no differences in food intake were observed between wildtype and PPARaÀ/À mice ( Figure 2D ). Also, no differences in the weight of the inguinal WAT, gonadal WAT, and interscapular BAT depots were observed between wildtype and PPARaÀ/À mice, neither in the thermoneutral nor in the cold-exposed mice ( Figure 2E ). To examine any potential morphological differences in the inguinal WAT of wildtype and PPARaÀ/À mice, we performed H&E staining ( Figure 2F ). The inguinal WAT of both sets of mice showed the characteristic features of browning, as revealed by the presence of numerous multilocular brown fat-like cells. However, no obvious differences could be observed in the degree of browning between the wildtype and PPARaÀ/À mice ( Figure 2F ). Next, we measured the levels of various metabolites in the blood plasma. In the cold-exposed mice, levels of non-esterified fatty acids and cholesterol were significantly higher in plasma of PPARaÀ/À mice compared to wildtype mice, a finding which was not observed under thermoneutral conditions (Figure 3 ). By contrast, plasma levels of triglycerides, glycerol, ketones, and glucose were not significantly different between cold-exposed PPARaÀ/À and wildtype mice. These data indicate that the absence of PPARa leads to a modest metabolic phenotype in cold-exposed mice.
3.3. Cold induces similar changes in gene expression in wildtype and PPARaÀ/À mice at the whole genome level To gain insight into the role of PPARa in cold-induced browning, we performed whole genome expression profiling on the inguinal WAT depot of wildtype and PPARaÀ/À mice exposed to thermoneutrality or cold. As a strong positive reference for PPARa-dependent gene regulation, a parallel whole genome expression analysis was performed on the livers of wildtype and PPARaÀ/À mice subjected to fasting for 24 h or fed ad libitum. Volcano plot analysis indicated that the differences in gene expression in inguinal WAT between cold-exposed wildtype and PPARaÀ/À mice are very modest (Figure 4A ), certainly when compared with the differences in liver gene expression between wildtype and PPARaÀ/À mice after fasting ( Figure 4B ). Indeed, after cold, expression of only 50 genes was significantly lower and expression of 20 genes was significantly higher in inguinal WAT of PPARaÀ/À mice as compared to wildtype mice (P < 0.001, fold-change>1.2) ( Figure 4C ). By comparison, after fasting, expression of 1224 genes was significantly lower and expression of 1328 genes was significantly higher in the liver of PPARaÀ/À mice as compared to wildtype mice (P < 0.001, fold-change>1.2) ( Figure 4C ). Principle component analysis and hierarchical clustering clearly separated the inguinal WAT samples of the cold-exposed mice and the thermoneutral mice, illustrating the pronounced impact of cold on overall gene expression in inguinal WAT ( Figure 5A ). However, within the cold and thermoneutral groups, wildtype and PPARaÀ/À mice did not separate into distinct clusters, suggesting a minimal effect of PPARa deletion on overall gene regulation in cold-exposed inguinal WAT. By contrast, principle component analysis and hierarchical clustering markedly separated the livers of fasted wildtype and PPARaÀ/À mice ( Figure 5B ). Scatter plot analysis confirmed that the effect of cold on overall gene expression in inguinal WAT is nearly identical in wildtype and PPARaÀ/À mice ( Figure 5C ). Also, the cold-induced changes in gene expression of several classical PPARa target genes was virtually identical in inguinal WAT of wildtype and PPARaÀ/À mice ( Figure 5C , red dots). By contrast, the effect of fasting on overall gene expression in liver was very distinct between wildtype and PPARaÀ/À mice, illustrating the importance of PPARa in hepatic gene regulation during fasting ( Figure 5D ). These data indicate that at the whole genome level, inguinal WAT of PPARaÀ/À mice cannot be distinguished from inguinal WAT of wildtype mice, both at thermoneutral and cold conditions. In contrast, livers of PPARaÀ/À mice can easily be distinguished from wildtype mice, in particular after fasting.
3.4. Cold-sensitive pathways are similarly induced in inguinal WAT in wildtype and PPARaÀ/À mice To further evaluate the browning effect in wildtype and PPARaÀ/À mice, we compared the effect of cold on biological pathways in the two sets of mice using Ingenuity Pathway Analysis and Gene Set Enrichment Analysis. The most significant cold-induced pathways in the wildtype mice were mainly related to the electron transport chain and oxidative phosphorylation ( Figure 6A ). Consistent with the data presented abovedshowing a lack of difference in cold-induced expression changes between wildtype and PPARaÀ/À micedthe enrichments scores for the cold-induced pathways were nearly identical in the wildtype mice and PPARaÀ/À mice ( Figure 6A) . Similarly, according to Ingenuity Pathway Analysis, the most significant coldinduced pathways in inguinal WAT were related to oxidative phosphorylation, the tricarboxylic acid cycle, fatty acid oxidation, and other catabolic pathways, and had very similar significance scores in wildtype and PPARaÀ/À ( Figure 6B) . Remarkably, the pathway named PPARA targets was equally induced by cold in wildtype and PPARaÀ/ À mice, indicating that PPARa is dispensable for regulation of PPARa targets by cold in inguinal WAT. By contrast, the results of Gene Set Enrichment Analysis and Ingenuity Pathway Analysis for the fastinginduced changes in hepatic gene expression were very distinct in the wildtype mice and PPARaÀ/À mice. Specifically, enrichment scores and significance scores for many pathways related to PPAR signaling and fatty acid catabolism were very high in the wildtype mice yet were much lower or even opposite in the PPARaÀ/À mice log-(P-value) for comparison between liver of wildtype and PPARaÀ/À mice after 24 h fasting. (C) Number of genes in inguinal WAT that are significantly different between wildtype and PPARaÀ/À mice after 10-day cold exposure, and the number of genes in liver that are significantly different between wildtype and PPARaÀ/À mice after 24 h fasting. The number of differentially expressed genes was calculated based on a statistical significance cut-off of P < 0.001 (IBMT regularized paired t-test) and fold-change >1.2. Genes were separated according to up-or down-regulation. ( Figure 6C,D) . Taken together, these data show that at the pathway level, the absence of PPARa does not have a noticeable influence on the induction of metabolic pathways by cold in inguinal WAT.
3.5. Cold-sensitive genes are similarly induced in inguinal WAT in wildtype and PPARaÀ/À mice To further zoom in at the level of individual genes, we selected the top 50 of most highly induced genes by cold exposure in inguinal WAT in the wildtype mice, ranked according to fold-change ( Figure 7A ). As expected, the most highly induced gene by cold was Ucp1, followed by other well-known cold-induced genes such as Elovl3, Cox7a1, and Cidea. This top 50 list also includes many well-established PPARa target genes in the liver, including Gyk, Gys2, Plin5, Pdk4, Hadhb, Slc25a20, Gpd2, and Acadvl, as well as Ppara itself ( Figure 7A ). Consistent with the data presented above, the cold-induced changes in gene expression were generally similar in the PPARaÀ/À mice. Out of the 641 genes that were induced by cold (fold-change>1.5, P < 0.001), only 5 genes had a significantly lower expression in the cold-exposed PPARaÀ/À mice than in the cold-exposed wildtype mice (fold-change <À1.5, P < 0.001). These genes include Original Article 48 2310069B03Rik, Adprhl1, and the established PPARa targets Slc27a2, Fbp2, and Ehhad [18] . A similar picture was observed for genes that were downregulated by cold ( Figure 7B ). Indeed, downregulation of gene expression by cold was generally unaffected in the PPARaÀ/À mice. Out of the 420 genes that were downregulated by cold (foldchange <À1.5, P < 0.001), only 2 genes had a significantly higher expression in the cold-exposed PPARaÀ/À mice than in the exposed wildtype mice (fold-change>1.5, P < 0.001), which were Vnn1 and Sema5a. These data suggest that except for a very limited number of genes, mostly representing direct PPARa target genes, the changes in gene expression in inguinal WAT induced by cold were nearly identical in wildtype and PPARaÀ/À mice. 3.6. Role of PPARa in in vitro browning Next, to examine the potential role of PPARa in in vitro browning, we first studied the differentiation of wildtype and PPARaÀ/À stromal vascular cells from inguinal WAT. Adipocyte differentiation was accompanied by the marked induction of classical adipogenic markers, including Pparg, Fabp4, Slc2a4, and Gpd1, as well as induction of brown adipocyte markers, such as Ppargc1a, Cidea, Elovl3, and Ucp1 ( Figure 8A) . Intriguingly, whereas induction of classical adipogenic markers was not different between wildtype and PPARaÀ/À adipocytes, expression of brown adipocyte markers was elevated in PPARaÀ/À compared to wildtype adipocytes ( Figure 8A ). These data do not support the notion that PPARa is required for the activation of the genes underlying browning. To investigate the ability of PPARa to activate in vitro browning in human adipocytes, we treated human primary adipocytes obtained from subcutaneous adipose tissue with the synthetic PPARa agonist GW7647. Consistent with previous data, GW7647 increased UCP1 mRNA levels ( Figure 8B ) [27] . In addition, GW7647 modestly upregulated the expression of PDK4, ADIPOQ, and ACADVL ( Figure 8B ). Despite the approximately 5-fold increase in UCP1 mRNA, no effect of GW7647 on norepinephrine-stimulated mitochondrial uncoupling or maximal respiration was detected in the cultured human adipocytes ( Figure 8C,D) . Hence, although pharmacological activation of PPARa in primary human adipocytes had a modest stimulatory effect on genes related to browning, these changes did not translate into metabolic changes in uncoupled respiration.
PPARg activation but not PPARa activation is able to markedly upregulate cold-induced genes in murine WAT
The in vivo and in vitro data presented above indicate that PPARa is not required for (cold-induced) adipose tissue browning. This conclusion suggests that a transcription factor other than PPARa may be responsible for the induction of PPAR target genes in inguinal WAT during cold. An obvious candidate is PPARg, as its expression in inguinal WAT is increased during cold ( Figure 9A ) [5] . In contrast, expression of PPARd was very stable in iWAT during cold-induced browning in all available microarray datasets (GSE13432, GSE01080, present study). To explore the possible role of PPARg, we compared the effect of PPARg and PPARa activation in mice on the expression of cold-induced genes in adipose tissue using transcriptomics ( Figure 9B ). In this experiment, wildtype mice were given rosiglitazone or Wy-14,643 in the food for 1 week. Whereas PPARg activation by rosiglitazone markedly induced the expression of cold-induced genes in WAT, PPARa activation by Wy-14,643 had a minimal effect ( Figure 9B ). The most highly induced genes by Wy-14,643 in WAT were the PPARa targets Vnn1 (2.2-fold) and Fabp1 (3.2-fold), neither of which are induced by cold. These data indicate that PPARg activation but not PPARa activation is able to markedly upregulate cold-induced genes in murine WAT.
Chronic cold does not lead to activation of PPARa in the liver
Recently, it was demonstrated that short term cold exposure increases plasma long chain acyl-carnitine levels [43] , concomitant with induction of the hepatic expression of several enzymes involved in acylcarnitine metabolism. Since many of these enzymes are under transcriptional control of PPARa, we explored the possibility that PPARa may be important for regulating lipid metabolism in the liver during cold. To that end, we measured the hepatic expression of several genes involved in acylcarnitine metabolism, as well as other target genes of PPARa, in thermoneutral and cold-exposed wildtype and PPARaÀ/À mice ( Figure 10A ). While the expression of most genes studied was reduced in the liver of PPARaÀ/À mice, no Figure 9 : PPARg activation but not PPARa activation is able to markedly upregulate coldinduced genes in murine WAT. A) Relative gene expression of Pparg in gonadal WAT and inguinal WAT of wildtype mice after 10 days at 28 C (warm, n ¼ 6e8) or 5 C (cold, n ¼ 10) [51] . Data are presented as mean AE SEM. Asterisk indicates significantly different from thermoneutral mice according to Student's t-test (**P < 0.01). B) Comparative analysis was performed between whole genome expression changes in WAT in response to 10-day cold exposure and in response to 7-day treatment with rosiglitazone (0.01 % wt/wt of feed) or Wy-14,643 (0.1 % wt/wt of feed). The top 25 most highly induced genes by 10-day cold exposure in WAT of wildtype mice were selected. The effect of 1-week treatment with rosiglitazone or Wy-14,643 on the expression of these genes in WAT of wildtype mice is shown (GSE11295). The top 25 list differs from Figure 7 , because certain genes were either not present on the microarray used for the rosiglitazone/Wy-14,643 study or did not meet the filtering criteria.
interaction was observed between cold and loss of PPARa, meaning that the effect of loss of PPARa was comparable in cold and thermoneutral conditions ( Figure 10A ). An exception was Fabp1, expression of which was lower in PPARaÀ/À mice compared to wildtype mice at 5 C but not at 28 C. Importantly, the expression of genes involved in acylcarnitine metabolism and of other PPARa targets was refractory to cold. In line with the gene expression data, liver triglyceride levels were higher in the PPARaÀ/À mice compared to wildtype mice, yet levels were similar in the cold and thermoneutral conditions ( Figure 10B ). To assess the potential role of PPARa in liver during acute cold, we measured the hepatic expression of the same set of genes in wildtype and PPARaÀ/À mice exposed to cold for 24 h. Although acute cold caused the marked upregulation of Cpt1a and Slc22a5, both of which are involved in acylcarnitine metabolism, the induction was similar in wildtype and PPARaÀ/À mice (Supplemental Figure 2) . Other PPARa targets were only weakly activated or not activated at all by acute cold. Together, these data indicate that the role of PPARa in liver does not become more important during acute or chronic cold, suggesting that cold does not lead to activation of PPARa in the liver, unlike during fasting.
DISCUSSION
Little is known about the regulatory mechanisms driving the metabolic adaptations during cold-induced browning. Whereas previous studies have found that loss of PPARa leads to attenuation of CL316,243-induced adipose tissue browning [27, 29] , here we find that PPARa, despite its marked upregulation in inguinal WAT by cold, is completely dispensable for cold-induced browning in mice. Histological analysis of inguinal WAT showed clear browning upon cold but did not reveal any morphological differences between wildtype and PPARaÀ/À mice. Transcriptomics analysis showed that the cold-induced changes in gene expression in inguinal WAT were fully maintained in the absence of PPARa at the whole genome level, the pathway level, and the level of individual genes. Indeed, cold-sensitive thermogenic genes such as Ucp1 and Elovl3 and numerous others were similarly induced by cold in wildtype and PPARaÀ/À mice. Overall, our data indicate that PPARa is not required for cold-induced browning in inguinal WAT. The lack of effect of PPARa ablation on gene expression in inguinal WAT during cold contrasts starkly with the dramatic effect of PPARa ablation on gene expression in liver during fasting, a well-known PPARa-driven phenomenon. Several studies have examined the role of PPARa in in vivo adipose tissue browning, either by treating mice with synthetic PPARa agonists or by using PPARaÀ/À mice, yielding somewhat conflicting results. For example, whereas in one study, chronic treatment of mice with the PPARa agonist fenofibrate led to the induction of thermogenic genes and the appearance of multilocular adipocytes in WAT [44] , in another study, chronic treatment with fenofibrate failed to cause an increase in multilocular adipocytes in WAT [24] . Treatment of wildtype mice with CL316,243 upregulated PPARa mRNA in white adipose tissue by 10-fold, suggesting a potential role of PPARa in CL316,243-induced browning. Interestingly, CL316,243 triggered morphological changes characteristic of browning in WAT of wildtype but not PPARaÀ/À mice [29] . Transcriptomics analysis showed that the time-dependent expression changes in WAT following CL316,243 treatment were attenuated in PPARaÀ/À mice [29] . In agreement with the known role of PPARa in regulating fatty acid catabolism, many of the affected genes were involved in the transport/activation and oxidation of fatty acids. In another study, induction of thermogenic genes such as Ucp1, Elovl3, and Cpt1b by CL316,243 was shown to be attenuated in the absence of PPARaÀ/À, both at room temperature and at thermoneutrality [27] . These data suggest that PPARa has a stimulatory role in CL316,243-induced adipose tissue browning. By contrast, our data indicate that PPARa is not required for coldinduced browning. It thus appears that the role of PPARa may be different between CL316,243-induced browning and cold-induced browning. The reason for this difference is not clear but may be related to the more diverse effects of cold versus the more targeted mechanism of action of CL316,243. Alternatively, the possible compensatory role of PPARg (see below) may be more readily recruitable during cold-induced browning than during CL316,243-induced browning. Previously, it was shown that PPARa and PPARg can regulate partially overlapping gene sets [45] . Based on our data, it is not possible to distinguish between the possibility that in wildtype mice: 1) PPARa is not at all involved in gene regulation in inguinal WAT during cold, or 2) PPARa drives the expression of several cold-induced genes in inguinal WAT, yet PPARg takes over the role of PPARa in PPARaÀ/À mice. The second scenario is reminiscent of the ability of PPARg to compensate for the absence of PPARa in livers of PPARaÀ/À mice chronically fed a high fat diet [46] . In that situation, the expression of PPARg goes up dramatically [46] . In favor of the first possibility, transcriptomics did not reveal a compensatory increase in PPARg expression in inguinal WAT of PPARaÀ/À mice. Moreover, in contrast to PPARg activation, PPARa activation had only minimal effects on thermogenic gene expression in WAT of wildtype mice. Accordingly, activation of PPARg but not PPARa likely is a major driver of cold-induced changes in gene expression in inguinal white adipocytes. Even though several cold-induced genes involved in fatty acid catabolism are primarily known as targets of PPARa, it has been shown that under certain conditions, PPARg is capable of upregulating classical PPARa targets [46, 47] . Why PPARa is dramatically upregulated in inguinal WAT during cold if it is not involved in regulating gene expression, remains unclear. The dispensable role of PPARa in cold-induced browning is consistent with the recent finding that PPARa is not required for in vivo brown fat function [48] . In contrast to Ppara and Pparg, the expression of Ppard in inguinal WAT is completely refractory to cold. Although the lack of change in Ppard expression does not rule out a role of PPARd in cold-induced browning, it does make it unlikely. Arguing against a role of PPARd in adipose tissue browning, PPARd was recently shown to be dispensable for brown fat function [48] . Our experiments and studies of others in primary human adipocytes showed that PPARa activation leads to increased expression of brown fat markers such as UCP1, CIDEA, ELOVL3, and CPT1B [27] . Furthermore, when analyzed by transcriptomics, PPARa and PPARg activation in primary human adipocytes caused the induction of largely overlapping gene sets, reflecting a browning of human white adipocytes [27] . To what extent these changes upon pharmacological PPARa activation reflect a physiological role of PPARa in in vitro browning remains unclear. Unfortunately, technical limitations preclude investigation of the influence of inactivation of PPARa on in vitro features of browning in primary human adipocytes. In our study, 10 days of cold exposure caused a large increase in food intake, while it did not change the bodyweight of the mice, underlining the profound increase in energy demand during cold exposure in mice. The huge increase in energy expenditure and thermogenesis allowed the mice to maintain a stable body temperature during the entire 10-day intervention. Importantly, no differences in body temperature were observed between the two genotypes, except for the first 12 h of cold acclimation, during which the PPARaÀ/À mice had a slightly lower body temperature. The more significant drop in body temperature in the PPARaÀ/À mice during the first hours of cold exposure is likely caused by the semi-fasting of the mice in the light cycle, when the mice are sleeping. Indeed, fasting by itself has been shown to provoke hypothermia in whole body and liver-specific PPARaÀ/À mice [15, 49] . Based on these considerations, the previously observed decline in body temperature in PPARaÀ/À mice upon 3 h of cold exposure is probably due to the fact that the mice were fasted at the same time and might not reflect a role of PPARa in cold-induced thermogenesis per se [50] . Recently, it was shown that short term cold exposure leads to elevation of plasma long chain acyl-carnitine levels, concomitant with induction of the expression of enzymes involved in acylcarnitine metabolism in the liver, including Cpt1b, Slc22a5, Slc25a20, and Crat [43] . A mechanism was proposed in which NEFA derived from adipose tissue lipolysis activate the nuclear receptor HNF4a in the liver, leading to induction of genes involved in acyl-carnitine production. Since the above genes are all direct targets of PPARa, which is activated by fatty acids, it can be hypothesized that apart from HNF4a, PPARa may also be involved in the stimulation of acyl-carnitine synthesis during short term cold. In our study, however, we could not find any evidence for upregulation of genes involved in carnitine synthesis after chronic cold. In addition, other target genes of PPARa were also not induced in the liver after chronic cold. Interestingly, hepatic expression of Cpt1a and Slc22a5, both of which are involved in acylcarnitine metabolism, was elevated by acute cold. However, this induction was independent of PPARa. Overall, these data suggest that hepatic PPARa is not activated by acute or chronic cold. Intriguingly, hepatic expression of Fabp1 was lower in PPARaÀ/À mice specifically at 5 C, which may account for the elevated NEFA levels in PPARaÀ/À mice during cold.
In conclusion, we find that cold-induced changes in gene expression in inguinal WAT are unaltered in mice lacking PPARa, indicating that PPARa is dispensable for cold-induced browning.
